Form 8-K - Current report:
SEC Accession No. 0001558370-19-008204
Filing Date
2019-08-15
Accepted
2019-08-15 08:02:34
Documents
1
Period of Report
2019-08-12
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 50221
  Complete submission text file 0001558370-19-008204.txt   51404
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 191028512
SIC: 2834 Pharmaceutical Preparations